A randomized phase II study of chemoradiation and pembrolizumab for locally advanced cervical cancer

被引：1
|
作者：
Duska, Linda [1 ]
Romano, Kara [1 ]
Holman, Laura [2 ]
Crane, Erin [3 ]
Wethington, Stephanie [4 ]
Fields, Emma [5 ]
Randall, Leslie [5 ]
Schwarz, Julie [6 ]
Petroni, Gina [1 ]
Bullock, Timothy [1 ]
Scalici, Jennifer [7 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Univ Oklahoma, Oklahoma City, OK USA
[3] Levine Canc Inst, Charlotte, NC USA
[4] Johns Hopkins Univ, Baltimore, MD USA
[5] Virginia Commonwealth Univ, Richmond, VA USA
[6] Washington Univ, St Louis, MO USA
[7] Mitchell Canc Inst, Mobile, AL USA
来源：
GYNECOLOGIC ONCOLOGY | 2023年 / 176卷
关键词：
D O I：
10.1016/j.ygyno.2023.06.471
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
005
引用
收藏
页码：S5 / S5
页数：1
相关论文
共 50 条
  • [31] A Phase 3 Study of Pembrolizumab plus Chemoradiotherapy for High-Risk Locally Advanced Cervical Cancer
    Cerrotta, Annamaria
    Macchia, Gabriella
    Christiaens, Melissa
    Lalondrelle, Susan
    Zhang, Xiang
    De Melo, Andreia Cristina
    Reginacova, Klaudia
    Helpman, Limor
    Ayhan, Ali
    Zagouri, Flora
    Woelber, Linn
    Hellman, Kristina
    Colombo, Nicoletta
    Romeo Marin, Margarita
    Berger, Regina
    Alejandra Lopez, Karla
    Castonguay, Vincent
    Takehara, Kazuhiro
    Chang, Ting-Chang
    Yamada, Karin
    Toker, Sarper
    Li, Kan
    Lorusso, Domenica
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1124 - S1126
  • [32] Phase II study of definitive chemoradiation for locally advanced squamous cell cancer of the vulva: An efficacy study
    van Triest, Baukelien
    Rasing, Marnix
    van der Velden, Jacobus
    de Hullu, Joanne
    Witteveen, Petronella O.
    Beukema, Jannet C.
    Van der Steen-Banasik, Elsbieta
    Westerveld, Henrike
    Snyers, An
    Peters, Max
    Creutzberg, Carien L.
    Nout, Remi A.
    Lutgens, Ludy
    Jurgenliemk-Schulz, Ina
    GYNECOLOGIC ONCOLOGY, 2021, 163 (01) : 117 - 124
  • [33] Prospective phase II study of tomotherapy based chemoradiation treatment for locally advanced anal cancer
    Joseph, Kurian
    Nijjar, Yugmel
    Warkentin, Heather
    Schiller, Dan
    Tankel, Keith
    Usmani, Nawaid
    Severin, Diane
    Ghosh, Sunita
    Syme, Alasdair
    Nijjar, Tirath
    Mulder, Karen
    Doll, Corinne
    Wong, Clarence
    Field, Colin
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (02) : 234 - 239
  • [34] FASE II TRIAL OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY CHEMORADIATION IN LOCALLY ADVANCED CERVICAL CANCER
    Azevedo, C. R. A. S.
    Thuler, L. C. S.
    Mello, M. J. G. D.
    Ferreira, C. G.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 291 - 291
  • [35] MITO CERV3_PHASE II STUDY ON CARBOPLATIN-PACLITAXEL-PEMBROLIZUMAB IN NEOADJUVANT TREATMENT OF LOCALLY ADVANCED CERVICAL CANCER
    Salutari, Vanda
    Camarda, Floriana
    Musacchio, Lucia
    Scalone, Simona
    Savarese, Antonella
    Gori, Stefania
    Carbone, Maria Vittoria
    Nero, Camilla
    Vici, Patrizia
    Bergamini, Alice
    Zamagni, Claudio
    Scambia, Giovanni
    Lorusso, Domenica
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A224 - A225
  • [36] Pembrolizumab plus Chemoradiotherapy for locally advanced Cervical Cancer - the prospective, randomized KEYNOTE-A18 Phase 3 Trial
    Trommer, Maike
    Gaasch, Aurelie
    Corradini, Stefanie
    STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (11) : 994 - 996
  • [37] A randomized, phase III trial of induction chemotherapy followed by chemoradiation compared with chemoradiation alone in locally advanced cervical cancer: The GCIG INTERLACE Trial
    Ledermann, Jonathan
    McCormack, Mary
    Gallardo Rincon, Dolores
    Eminowicz, Gemma
    Diez, Patricia
    Farrelly, Laura
    Kent, Christopher
    Hudson, Emma
    Panades, Miguel
    Mathew, Tony
    Anand, Anjana
    Persic, Mojca
    Forrest, Jennifer
    Bhana, Rajanee
    Reed, Nick
    Drake, Anne
    Stobart, Hilary
    Mukhopadhyay, Asima
    Hacker, Anne-Marie
    Hackshaw, Allan
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S21 - S21
  • [38] Chemotherapy induction followed by preoperative chemoradiation versus preoperative chemoradiation alone in locally advanced rectal cancer (LARC): A randomized controlled phase II study.
    Marechal, R.
    Vos, B.
    Polus, M.
    Delaunoit, T.
    Peeters, M.
    Demetter, P.
    Van Houtte, P.
    Demols, A.
    Van de Stadt, J.
    Van Laethem, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [39] Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: a phase II, randomized study
    Skipar, Kjersti
    Hompland, Tord
    Lund, Kjersti V.
    Fjeldbo, Christina S.
    Lindemann, Kristina
    Hellebust, Taran P.
    Lyng, Heidi
    Bruheim, Kjersti
    ACTA ONCOLOGICA, 2025, 64 : 439 - 447
  • [40] Phase II study of tislelizumab combined with concurrent chemoradiotherapy for locally advanced cervical cancer
    Ma, Shanshan
    Zhang, Yong
    Wu, Fang
    Jiang, Li
    Zhang, Tingting
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345